Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood.

Authors: Rütten Simon, Schusser Gerald F, Abraham Getu, Schrödl Wieland

Journal: BMC veterinary research

DOI: 10.1186/s12917-016-0742-4 PubMed: 27316332Log in to save

Summary

# Editorial Summary Equine practitioners have long recognised that horses mount disproportionately vigorous inflammatory responses compared to other species, yet measuring the kinetics of key inflammatory mediators in clinical or research settings has remained technically challenging. Rütten and colleagues developed and validated simplified ex-vivo methods to quantify tumour necrosis factor-α (TNF-α) and interleukin-1 receptor antagonist (IL-1Ra) release from whole blood cultures across specific timepoints and lipopolysaccharide concentrations, establishing reproducible baselines for equine systemic inflammation. The work addresses a genuine gap in equine immunology: whilst we understand that horses exhibit excessive PMN and PBMC recruitment with corresponding cytokine cascades in response to inflammatory triggers, having standardised, cost-effective laboratory protocols matters considerably for both clinical diagnostics and research into conditions ranging from sepsis to endotoxaemia. These methods now provide farriers, veterinarians and allied professionals with practical tools for understanding individual variation in inflammatory capacity—information that could inform treatment strategies, prognostication, and potentially guide management decisions in acute inflammatory conditions where early cytokine profiling might offer clinical advantage. The relative simplicity and reproducibility of these assays make them accessible beyond specialist research facilities, potentially enabling wider adoption in equine practice settings.

Read the full abstract on PubMed

Practical Takeaways

•This work establishes practical laboratory methods for measuring inflammatory markers (TNF-α and IL-1Ra) in equine blood, which could help identify inflammatory status in clinical cases
•The ex vivo whole blood culture approach may provide a more physiologically relevant assessment of inflammatory response than other methods
•These measurement techniques could be applied to monitor inflammatory conditions, though clinical validation would be needed before routine use in practice

Key Findings

•Developed reproducible ex vivo methods for measuring TNF-α and IL-1Ra in equine whole blood cultures
•Demonstrated time- and concentration-dependent release kinetics of inflammatory cytokines in equine blood
•Methods are described as easy, quick, cheap and reproducible for equine inflammatory assessment

Conditions Studied

inflammatory responsecytokine releasepolymorphonuclear granulocyte recruitment

Related References

Effect of lipopolysaccharide infusion on gene expression of inflammatory cytokines in normal horses in vivo.

Nieto J E, MacDonald M H, Braim A E Poulin, Aleman M(2009)Equine veterinary journal

Characterization and differentiation of equine experimental local and early systemic inflammation by expression responses of inflammation-related genes in peripheral blood leukocytes.

Vinther Anne Mette L, Heegaard Peter M H, Skovgaard Kerstin, Buhl Rikke, Andreassen Stine M, Andersen Pia H(2016)BMC veterinary research

Dynamic expression of leukocyte innate immune genes in whole blood from horses with lipopolysaccharide-induced acute systemic inflammation.

Vinther Anne Mette L, Skovgaard Kerstin, Heegaard Peter M H, Andersen Pia H(2015)BMC veterinary research

mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin.

Andreassen Stine Mandrup, Berg Lise C, Nielsen Søren Saxmose, Kristensen Annemarie T, Jacobsen Stine(2015)BMC veterinary research

Proinflammatory cytokine responses of cultured equine keratinocytes to bacterial pathogen-associated molecular pattern motifs.

Leise B S, Yin C, Pettigrew A, Belknap J K(2010)Equine veterinary journal

Release kinetics of tumor necrosis factor-&#x3b1; and interleukin-1 receptor antagonist in the equine whole blood.